DCG-IV is a research drug which acts as a group-selective agonist for the group II metabotropic glutamate receptors (mGluR2/3). It has potent neuroprotective and anticonvulsant effects in animal studies as well as showing anti-Parkinsonian effects but also impairs the formation of memories.
This page contains content from the copyrighted Wikipedia article "DCG-IV"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
